XTANT MEDICAL HOLDINGS, INC. (XTNT) Free cash flow
- Free cash flow · 12 months (USD): Value $-696.00K; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value -0.64%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-696.00K | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $570.00K − $1.27M ≈ $-696.00K |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | -0.64% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $-696.00K ÷ $109.53M × 100 ≈ -0.64% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $570.00K | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | -0.04× | Operating cash flow / net income. Period ending 2026-06-30. $570.00K ÷ $-16.11M ≈ -0.04× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 570.00K USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 1.27M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -696.00K USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 109.53M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -16.11M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $-696.00K | (m) | $570.00K | $1.27M | (m) | $109.53M | (m) | $-16.11M | (m) | (m) | -0.64% | -0.04× |
| 2026-03-31 | $7.77M | (m) | $9.15M | $1.39M | (m) | $121.91M | (m) | $1.83M | (m) | (m) | 6.37% | 5.01× |
| 2025-12-31 | $10.16M | (m) | $12.55M | $2.38M | (m) | $133.93M | (m) | $4.97M | (m) | (m) | 7.59% | 2.52× |
| 2025-09-30 | $5.17M | (m) | $7.83M | $2.66M | (m) | $133.08M | (m) | $1.75M | (m) | (m) | 3.89% | 4.47× |
| 2025-06-30 | $-2.83M | (m) | $1.50M | $4.33M | (m) | $127.77M | (m) | $-4.58M | (m) | (m) | -2.22% | -0.33× |
| 2025-03-31 | $-9.39M | (m) | $-4.86M | $4.53M | (m) | $122.30M | (m) | $-11.99M | (m) | (m) | -7.68% | 0.41× |
| 2024-12-31 | $-16.01M | (m) | $-11.90M | $4.11M | (m) | $117.27M | (m) | $-16.45M | (m) | (m) | -13.65% | 0.72× |
| 2024-09-30 | $-17.28M | (m) | $-13.48M | $3.80M | (m) | $113.86M | (m) | $-17.59M | (m) | (m) | -15.18% | 0.77× |
| 2024-06-30 | $-17.52M | (m) | $-15.59M | $1.92M | (m) | $110.94M | (m) | $-3.33M | (m) | (m) | -15.79% | 4.68× |
| 2024-03-31 | $-14.80M | (m) | $-13.03M | $1.77M | (m) | $101.23M | (m) | $-1.66M | (m) | (m) | -14.62% | 7.84× |
| 2023-12-31 | $-10.97M | (m) | $-9.52M | $1.46M | (m) | $91.30M | (m) | $660.00K | (m) | (m) | -12.02% | -14.42× |
| 2023-09-30 | $-12.42M | (m) | $-10.89M | $1.54M | (m) | $78.47M | (m) | $2.75M | (m) | (m) | -15.83% | -3.95× |
| 2023-06-30 | $-10.94M | (m) | $-9.12M | $1.82M | (m) | $67.91M | (m) | $-8.83M | (m) | (m) | -16.11% | 1.03× |
| 2023-03-31 | $-8.32M | (m) | $-6.58M | $1.74M | (m) | $62.95M | (m) | $-8.35M | (m) | (m) | -13.21% | 0.79× |
| 2022-12-31 | $-7.11M | (m) | $-5.34M | $1.76M | (m) | $57.97M | (m) | $-8.48M | (m) | (m) | -12.26% | 0.63× |
| 2022-09-30 | $-4.58M | (m) | $-2.63M | $1.95M | (m) | $56.67M | (m) | $-8.56M | (m) | (m) | -8.08% | 0.31× |
| 2022-06-30 | $-3.34M | (m) | $-1.49M | $1.85M | (m) | $55.98M | (m) | $-8.01M | (m) | (m) | -5.96% | 0.19× |
| 2022-03-31 | $-1.31M | (m) | $742.00K | $2.06M | (m) | $55.68M | (m) | $-7.03M | (m) | (m) | -2.36% | -0.11× |
| 2021-12-31 | $-1.68M | (m) | $439.00K | $2.12M | (m) | $55.26M | (m) | $-4.85M | (m) | (m) | -3.03% | -0.09× |
| 2021-09-30 | $-1.20M | (m) | $932.00K | $2.13M | (m) | $55.31M | (m) | $-3.27M | (m) | (m) | -2.16% | -0.28× |
| 2021-06-30 | $-164.00K | (m) | $1.79M | $1.95M | (m) | $55.55M | (m) | $-2.83M | (m) | (m) | -0.30% | -0.63× |
| 2021-03-31 | $-2.08M | (m) | $-249.00K | $1.83M | (m) | $51.10M | (m) | $-4.56M | (m) | (m) | -4.07% | 0.05× |
| 2020-12-31 | $-2.28M | (m) | $-731.00K | $1.54M | (m) | $53.34M | (m) | $-7.02M | (m) | (m) | -4.27% | 0.10× |
| 2020-09-30 | $-3.10M | (m) | $-1.72M | $1.38M | (m) | $56.29M | (m) | $-7.92M | (m) | (m) | -5.51% | 0.22× |
| 2020-06-30 | $-4.28M | (m) | $-2.94M | $1.34M | (m) | $57.99M | (m) | $-8.44M | (m) | (m) | -7.39% | 0.35× |
| 2020-03-31 | $-3.69M | (m) | $-2.69M | $1.00M | (m) | $62.73M | (m) | $-7.92M | (m) | (m) | -5.89% | 0.34× |
| 2019-12-31 | $-1.29M | (m) | $-413.00K | $879.00K | (m) | $64.68M | (m) | $-8.22M | (m) | (m) | -2.00% | 0.05× |
| 2019-09-30 | (m) | (m) | $1.65M | (m) | (m) | $65.98M | (m) | $-63.31M | (m) | (m) | (m) | -0.03× |
| 2019-06-30 | (m) | (m) | $1.82M | (m) | (m) | $67.53M | (m) | $-64.58M | (m) | (m) | (m) | -0.03× |
| 2019-03-31 | (m) | (m) | $1.47M | (m) | (m) | $71.00M | (m) | $-67.64M | (m) | (m) | (m) | -0.02× |
| 2018-12-31 | (m) | (m) | $1.21M | (m) | (m) | $72.20M | (m) | $-70.10M | (m) | (m) | (m) | -0.02× |
| 2018-09-30 | (m) | (m) | $-133.18K | (m) | (m) | (m) | (m) | $-41.83M | (m) | (m) | (m) | 0.00× |
| 2018-06-30 | (m) | (m) | $556.82K | (m) | (m) | (m) | (m) | $-47.19M | (m) | (m) | (m) | -0.01× |
| 2018-03-31 | (m) | (m) | $-744.18K | (m) | (m) | $78.46M | (m) | $-51.88M | (m) | (m) | (m) | 0.01× |
| 2017-12-31 | (m) | (m) | $-543.18K | (m) | (m) | $82.61M | (m) | $-52.41M | (m) | (m) | (m) | 0.01× |
| 2017-09-30 | (m) | (m) | $-4.40M | (m) | (m) | $87.75M | (m) | $-28.53M | (m) | (m) | (m) | 0.15× |
| 2017-06-30 | (m) | (m) | $-7.41M | (m) | (m) | $91.05M | (m) | $-24.91M | (m) | (m) | (m) | 0.30× |
| 2017-03-31 | (m) | (m) | $-15.00M | (m) | (m) | $91.11M | (m) | $-19.68M | (m) | (m) | (m) | 0.76× |
| 2016-12-31 | (m) | (m) | $-14.41M | (m) | (m) | $90.00M | (m) | $-19.49M | (m) | (m) | (m) | 0.74× |
| 2016-09-30 | (m) | (m) | $-11.27M | (m) | (m) | $87.79M | (m) | $-3.37M | (m) | (m) | (m) | 3.34× |
| 2016-06-30 | (m) | (m) | $-12.76M | (m) | (m) | $82.39M | (m) | $-5.16M | (m) | (m) | (m) | 2.47× |
| 2016-03-31 | (m) | (m) | $-5.99M | (m) | (m) | $70.82M | (m) | $-3.59M | (m) | (m) | (m) | 1.67× |
| 2015-12-31 | (m) | (m) | $-9.10M | (m) | (m) | $59.35M | (m) | $-2.17M | (m) | (m) | (m) | 4.18× |
| 2015-09-30 | (m) | (m) | $-11.18M | (m) | (m) | $46.17M | (m) | $-17.06M | (m) | (m) | (m) | 0.66× |
| 2015-06-30 | (m) | (m) | $-7.54M | (m) | (m) | $36.93M | (m) | $-11.54M | (m) | (m) | (m) | 0.65× |
| 2015-03-31 | (m) | (m) | $-7.21M | (m) | (m) | $35.92M | (m) | $-10.54M | (m) | (m) | (m) | 0.68× |
| 2014-12-31 | (m) | (m) | $-7.32M | (m) | (m) | $35.33M | (m) | $-10.51M | (m) | (m) | (m) | 0.70× |
| 2014-09-30 | (m) | (m) | $-4.88M | (m) | (m) | $34.51M | (m) | $-11.37M | (m) | (m) | (m) | 0.43× |
| 2014-06-30 | (m) | (m) | $-5.21M | (m) | (m) | $33.98M | (m) | $-14.58M | (m) | (m) | (m) | 0.36× |
| 2014-03-31 | (m) | (m) | $-4.80M | (m) | (m) | $33.37M | (m) | $-15.16M | (m) | (m) | (m) | 0.32× |
| 2013-12-31 | (m) | (m) | $-4.89M | (m) | (m) | $33.07M | (m) | $-12.69M | (m) | (m) | (m) | 0.39× |
| 2013-09-30 | (m) | (m) | $-8.16M | (m) | (m) | $32.94M | (m) | $-13.41M | (m) | (m) | (m) | 0.61× |
| 2013-06-30 | (m) | (m) | $-9.49M | (m) | (m) | $33.89M | (m) | $-11.55M | (m) | (m) | (m) | 0.82× |
| 2013-03-31 | (m) | (m) | $-10.13M | (m) | (m) | $33.83M | (m) | $-8.34M | (m) | (m) | (m) | 1.22× |
| 2012-12-31 | $-12.62M | (m) | $-10.79M | $1.83M | (m) | $32.98M | (m) | $-7.71M | (m) | (m) | -38.26% | 1.40× |
| 2012-09-30 | $-10.38M | (m) | $-8.75M | $1.63M | (m) | (m) | (m) | $-7.19M | (m) | (m) | (m) | 1.22× |
| 2012-06-30 | $-9.34M | (m) | $-7.78M | $1.56M | (m) | (m) | (m) | $-7.83M | (m) | (m) | (m) | 0.99× |
| 2012-03-31 | $-9.87M | (m) | $-8.71M | $1.15M | (m) | (m) | (m) | $-8.97M | (m) | (m) | (m) | 0.97× |
| 2011-12-31 | $-8.32M | (m) | $-7.36M | $962.31K | (m) | (m) | (m) | $-3.01M | (m) | (m) | (m) | 2.45× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-9.16M | (m) | $-8.37M | $783.05K | (m) | (m) | (m) | $-19.47M | (m) | (m) | (m) | 0.43× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |